Researchers at Vanderbilt University Medical Center isolated an antibody that blocks bird flu
On Dec. 12, 2019, Vanderbilt University Medical Center (VUMC) researchers James Crowe Jr., MD, and colleagues announced they…
Oregonian received life-saving heart valve repair without open-heart surgery
On Dec. 11, 2019, Dennis Eggers became the first patient in a new clinical trial to receive a…
PATH announced Nikolaj Gilbert as President and CEO
On Dec. 4, 2019, PATH announced that its Board of Directors had unanimously chosen global development leader Nikolaj…
Nanomix received CE Mark for diagnostic panel that aids in rapid identification of life-threatening infections
On Dec. 4. 2019, Nanomix announced that the company had received CE Mark for its S1 Assay for…
The Cold Spring Harbor Laboratory researchers identified gene behind spread of deadly breast cancer
On Dec. 3, 2019, the Cold Spring Harbor Laboratory researchers with colleagues at UConn Health and Jackson Laboratory…
FDA approved new sickle cell treatment based on clincal trial resutls from UTHSC’s Kenneth Ataga, MD
On Dec. 2, 2019, the U.S. Food and Drug Administration (FDA) announced it had approved the drug crizanlizumab…
SEHA, Mayo Clinic entered joint venture to operate Sheikh Shakhbout Medical City in the United Arab Emirates
On Nov. 24, 2019, Abu Dhabi Health Services Company, the largest healthcare network in the United Arab Emirates…
UCSD researchers provided new insights into a key pathway that controls critical cell division mechanisms
On Nov. 20, 2019, University of California San Diego (UCSD) researchers provided new insights into a key pathway…
The Cancer Prevention and Research Institute of Texas awarded 10 new recruitment grants
On Nov. 20, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) announced the recruitment of its…
Celgene acquired by Bristol-Myers Squibb
On Nov. 20, 2019. Bristol-Myers Squibb announced it had completed its acquisition of Celgene. On Jun. 29, 2015,…
Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of the Novo Broad Greenhouse
On Nov. 19, 2019, Novo Ventures and the Broad Institute of MIT and Harvard announced the launch of…
Researchers at UCSD School of Medicine successfully applied phage therapy in mice to treat alcohol-related liver disease
On Nov. 13, 2019, researchers at University of California San Diego (UCSD) School of Medicine announced that they…
Merck acquired San Diego’s Calporta for up to $576 million
On Nov. 12, 2019, Calporta Therapeutics, one of eight San Diego biotech companies Avalon Ventures created with GlaxoSmithKline,…
Abbott announced discovery of a new strain of HIV
On Nov. 6, 2019, Abbott announced that a team of its scientists identified a new subtype of the…
Researchers at UGA’s Center for the Ecology of Infectious Diseases received a $16 million grant to study tropical diseases
On Oct. 30, 2019, researchers at the University of Georgia’s Center for the Ecology of Infectious Diseases received…
Karmanos Cancer Institute established the McLaren Proton Therapy Center
On Oct. 30, 2019, the Barbara Ann Karmanos Cancer Institute established the McLaren Proton Therapy Center, one of…
Helmsley Foundation awarded $13 million in grants for the Gut Cell Atlas
On Oct. 27, 2019, the Leona M. and Harry B. Helmsley Charitable Trust announced it had awarded $13…
Sanford Burnham Prebys scientists developed a machine-learning algorithm that gleans information from microscope images
On Oct. 22, 2019, scientists at Sanford Burnham Prebys announced they had developed a machine-learning algorithm that gleans…
Lundbeck acquired Alder BioPharmaceuticals for $1.95 billion
On Oct. 22, 2019, Lundbeck, located in Valby, Denmark, announced it had completed its acquisition of Bothell, Washington-based…
Genentech announced FDA approval of antiviral drug Xofluza (Baloxavir Marboxil)
On Oct. 17, 2019, Genentech announced the U.S. Food and Drug Administration (FDA) had approved Xofluza (Baloxavir Marboxil),…
Penn Medicine received $22 million from NIH HEAL Initiative to combat the national opioid crisis
On Oct. 4, 2019, Penn Medicine announced they had received $22 Million from National Institutes of Health’s (NIH)…
New York State experienced measles outbreak
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
New York State declared measles free
On Oct. 3, 2019, the New York State Department of Health announced that more than 42 days –…
The Masonic Cancer Center and the University of Minnesota opened a first-in-human clinical trial for treatment of advanced solid tumors
On Oct. 2, 2019, the Masonic Cancer Center and the University of Minnesota (UM) opened a new first-in-human…
Emory Selected to lead international drug discovery center for Alzheimer’s
On Oct 1, 2019, the National Institute on Aging (NIA) announced it had awarded approximately $37 million over…
NIH grant awarded to Georgia Tech researchers to develop mRNA-based drug to correct hematopoietic stem cells
On Oct. 1, 2019, the National Institutes of Health (NIH) awarded a $3.5 million grant to Georgia Institute…
The NIH awarded up to $130 million over seven years for UGA to develop universal flu vaccine
On Sept. 30, 2019, the University of Georgia (UGA) announced it had signed a contract with the National…
Seattle Children’s received $30 million NIH funding to establish centers for TB vaccine development
On Sept. 26, 2019, Seattle Children’s announced it was one of three recipients of $30 million in first-year-funding…
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Radiology | Therapeutics
Karmanos, Wayne State received $3.1 million NIH grant to improve quality of life for African American cancer survivors
On Sept. 24, 2019 Karmanos, Wayne State announced it had received a $3.1 million National Institutes of Health…
Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center received a $9.2 million grant from the National Cancer Institute
On Sept. 23, 2019, the Barbara Ann Karmanos Cancer Institute and the University of Michigan Rogel Cancer Center…